Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) rose 1,346.6% during mid-day trading on Friday . The company traded as high as $0.45 and last traded at $0.45. Approximately 97 shares traded hands during trading, a decline of 100% from the average daily volume of 20,342 shares. The stock had previously closed at $0.03.
Cell MedX Price Performance
The stock has a 50-day moving average price of $0.09 and a 200 day moving average price of $0.05.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Read More
- Five stocks we like better than Cell MedX
- Stock Market Sectors: What Are They and How Many Are There?
- Tesla Investors Continue to Profit From the Trump Trade
- 3 Healthcare Dividend Stocks to Buy
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Canadian Penny Stocks: Can They Make You Rich?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
